arrow
L

Laura A. Dawson

University Health Network
H指数:87
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrity of delivered dose in temporally fractionated lattice Radiotherapy amid anatomical changes and setup uncertainties

在解剖结构变化和摆位不确定性的情况下,时序分次格架放射治疗的传递剂量完整性

2026-02-270
PRE
Reirradiation Collaborative Group (ReCOG) consensus on standards for dose evaluation and reporting in patients with multiple courses of radiation therapy: an AAPM/ACRO/ASTRO/CARO/COMP/CADRA/CPQR/ESTRO/NRG-endorsed consensus statement
2026-02-020
PRE
Health Related Quality of Life after SBRT for Oligoprogressive Disease: Results from a Phase II Prospective Trial

SBRT治疗寡进展性疾病后的健康相关生活质量:一项II期前瞻性试验的结果

2026-01-150
PRE
Reirradiation clinical practice in gastrointestinal abdominal malignancies: an international reirradiation collaborative group (ReCOG) systematic review

胃肠道腹癌的再放疗临床实践:一项国际再放疗协作组(ReCOG)系统评价

2025-08-130
OAAI
Patient-Reported Quality-of-Life Outcomes After Abdominopelvic Stereotactic Body Radiation Therapy Using an MR-Linac System

患者报告的腹腔立体定向体部放射治疗后生活质量结果:基于MR-Linac系统的研究

2025-03-300
OAAI
The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT): Oncologic Outcomes From a Phase 2 Nonrandomized Controlled Trial
2025-02-010
OAAI
Outcomes of Stereotactic Body Radiotherapy Compared with Surgical Resection in Patients with Hepatocellular Carcinoma and Macrovascular Invasion: A Propensity Score-Matched Analysis
2024-12-181
PRE
ASO Visual Abstract: Outcomes of Stereotactic Body Radiotherapy Compared with Surgical Resection in Patients with Hepatocellular Carcinoma and Macrovascular Invasion-A Propensity Score-Matched Analysis
2024-12-030
PRE
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET
2024-02-030
OAAI